Vyne Therapeutics Inc Cash Flow Quality Index

Latest as of March 2022: -1.94x

Vyne Therapeutics Inc cash flow quality index. Vyne Therapeutics Inc (VYNE) has a Cash Flow Quality Index of -1.94x as of March 2022. Operating cash flow of $-9.04 Million is below net income of $4.67 Million, suggesting accrual-heavy earnings not yet converted to cash. See Vyne Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.94x

Operating CF / Net Income

Operating Cash Flow

$-9.04 Million

USD

Net Income

$4.67 Million

USD

Data as of

Mar 2022

Most recent filing

Vyne Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Vyne Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Vyne Therapeutics Inc. For the full cash flow conversion analysis, see VYNE cash generation efficiency.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.